Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) price on current trading day, rose 2.76% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.49.
A look at the stock’s price movement, the close in the last trading session was $1.45, moving within a range at $1.42 and $1.52. The beta value (5-Year monthly) was 0.366 while the PE ratio in trailing twelve months stood at 137.96. Turning to its 52-week performance, $9.23 and $1.34 were the 52-week high and 52-week low respectively. Overall, IRWD moved -25.50% over the past month.
Ironwood Pharmaceuticals Inc’s market cap currently stands at around $238.44 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Analysts have a consensus estimate of 67.02M for the company’s revenue for the quarter, with a low and high estimate of 56M and 79.9M respectively. The average forecast suggests down to a -10.49% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 287.07M, representing a -18.31% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that IRWD is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend IRWD as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
IRWD’s current price about -6.05% and -39.10% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 32.87, while 7-day volatility ratio is 7.60% and 8.85% in the 30-day chart. Further, Ironwood Pharmaceuticals Inc (IRWD) has a beta value of 0.30, and an average true range (ATR) of 0.16. Analysts have given the company’s stock an average 52-week price target of $7, forecast between a low of $7 and high of $7. Looking at the price targets, the low is -369.8% off current price level while to achieve the yearly target high, price needs to move -369.8%. Nonetheless, investors will most likely welcome a -369.8% jump to $7 which is the analysts’ median price.
If we refocus on Ironwood Pharmaceuticals Inc (NASDAQ:IRWD), historical trading data shows that trading volumes averaged 2.24 over the past 10 days and 3.21 million over the past 3 months. The company’s latest data on shares outstanding shows there are 160.03 million shares.
The 3.02% of Ironwood Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 102.98% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 12.05 million on 2025-02-28, giving us a short ratio of 2.59. The data shows that as of 2025-02-28 short interest in Ironwood Pharmaceuticals Inc (IRWD) stood at 1456.0 of shares outstanding, with shares short rising to 10.75 million registered in 2025-01-31. Current price change has pushed the stock -66.37% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the IRWD stock continues to rise going into the next quarter.
